Blasé N. Polite

11.7k total citations · 2 hit papers
164 papers, 4.9k citations indexed

About

Blasé N. Polite is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Blasé N. Polite has authored 164 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 35 papers in Surgery. Recurrent topics in Blasé N. Polite's work include Colorectal Cancer Treatments and Studies (32 papers), Colorectal Cancer Screening and Detection (30 papers) and Economic and Financial Impacts of Cancer (27 papers). Blasé N. Polite is often cited by papers focused on Colorectal Cancer Treatments and Studies (32 papers), Colorectal Cancer Screening and Detection (30 papers) and Economic and Financial Impacts of Cancer (27 papers). Blasé N. Polite collaborates with scholars based in United States, China and Canada. Blasé N. Polite's co-authors include Olufunmilayo I. Olopade, James J. Dignam, James J. Dignam, Federico Innocenti, Alan P. Venook, Richard M. Goldberg, Charles D. Blanke, Heinz‐Josef Lenz, Donna Niedzwiecki and Monica M. Bertagnolli and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Blasé N. Polite

156 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

2015 436 citations Blasé N. Polite et al. profile →
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

2013 350 citations Blasé N. Polite et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Blasé N. Polite

Since Specialization

Citations

This map shows the geographic impact of Blasé N. Polite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blasé N. Polite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blasé N. Polite more than expected).

Fields of papers citing papers by Blasé N. Polite

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blasé N. Polite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blasé N. Polite. The network helps show where Blasé N. Polite may publish in the future.

Co-authorship network of co-authors of Blasé N. Polite

This figure shows the co-authorship network connecting the top 25 collaborators of Blasé N. Polite. A scholar is included among the top collaborators of Blasé N. Polite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blasé N. Polite. Blasé N. Polite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal 2026 ·Journal of Clinical Oncology ·(unknown), Kristen K. Ciombor, Lianchun Xiao, (unknown), Enrica Marmonti, Blasé N. Polite, Benjamin A. Weinberg, John C. Krauss, (unknown), (unknown), Olivia Aranha, (unknown), (unknown), (unknown), Syed Mohammad Ali Kazmi, Christopher H. Lieu, Howard S. Höchster, Jennifer G. Whisenant, Cara Haymaker, Cathy Eng	0
2	Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective 2025 ·Annals of Surgical Oncology ·Ryan P. Merkow, Michael J. Cavnar, Ana Gleisner, Skye C. Mayo, Sepideh Gholami, Paul J. Karanicolas, Bas Groot Koerkamp, Marjolein Y.V. Homs, Louise C. Connell, Andrea Cercek, Paul R. Helft, Blasé N. Polite, Reema Patel, Hope E. Uronis, Michael I. D’Angelica, Michael E. Lidsky	0
3	ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States 2025 ·JCO Oncology Practice ·Erin P. Balogh, Laura A. Levit, Joseph M. Unger, Melissa Accordino, David D. Chism, M. Kelsey Kirkwood, Helen M. Parsons, Manali I. Patel, Jeffrey Peppercorn, Blasé N. Polite, Mina S. Sedrak, Priyanka Sharma, Ishwaria M. Subbiah, Jennifer S. Temel, K. Robin Yabroff, Raymond U. Osarogiagbon	0
4	Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy 2024 ·JCO Precision Oncology ·David Su, (unknown), (unknown), Yuanyuan Zha, Ardaman Shergill, Blasé N. Polite, Lindsay Alpert, Kiran K. Turaga, Oliver S. Eng	2
5	Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers 2024 ·JCO Precision Oncology ·(unknown), (unknown), (unknown), Mohammad A. Zeineddine, David Su, (unknown), Chih‐Yi Liao, Blasé N. Polite, Oliver S. Eng, Keith F. Fournier, Michael G. White, Kiran K. Turaga, John Paul Shen, Ardaman Shergill	1
6	Mutational profiles and prognostic impact in colorectal and high‐grade appendiceal adenocarcinoma with peritoneal metastases 2023 ·Journal of Surgical Oncology ·(unknown), (unknown), (unknown), Cecilia T. Ong, Xiaoyang Wu, Ardaman Shergill, Blasé N. Polite, Kiran K. Turaga, Oliver S. Eng	3
7	Management of colorectal cancer during the COVID‐19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative 2021 ·Journal of Surgical Oncology ·Brian C. Brajcich, Al B. Benson, Gerald Gantt, Oliver S. Eng, Robert Marsh, Mary F. Mulcahy, Blasé N. Polite, Benjamin D. Shogan, Anthony D. Yang, Ryan P. Merkow	4
8	Health Equity for Black Americans: The Past Cannot Be Prologue 2021 ·JCO Oncology Practice ·Blasé N. Polite, Reginald Tucker‐Seeley, Karen M. Winkfield, Katherine Hicks-Courant	1
9	Oncology Medical Home: ASCO and COA Standards 2021 ·JCO Oncology Practice ·(unknown), Erin B. Kennedy, Kerin B. Adelson, (unknown), R.R. Brodie, Natalie R. Dickson, (unknown), Karen K. Fields, (unknown), Blasé N. Polite, (unknown), (unknown), (unknown), John V. Cox	21
10	Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405 2020 ·JNCI Cancer Spectrum ·Brendan J. Guercio, Sui Zhang, Alan P. Venook, Fang‐Shu Ou, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, (unknown), Bert H. O’Neil, James E. Shaw, Blasé N. Polite, Howard S. Höchster, James N. Atkins, Richard M. Goldberg, Justin C. Brown, Eileen M. O’Reilly, Robert J. Mayer, Charles D. Blanke, Charles S. Fuchs, Jeffrey A. Meyerhardt	8
11	Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies 2020 ·Surgery ·(unknown), Brian Ruhle, (unknown), Peter Angelos, Edwin L. Kaplan, Chih‐Yi Liao, Blasé N. Polite, Xavier M. Keutgen	6
12	Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases 2019 ·Cancer ·Abhineet Uppal, Fabrice Smieliauskas, (unknown), Steven B. Maron, Blasé N. Polite, Mitchell C. Posner, Kiran K. Turaga	12
13	Blase Polite on How Disparities Research Must Move Into an Era of Action. 2017 ·PubMed ·Blasé N. Polite	1
14	Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study 2017 ·Journal of Surgical Oncology ·Robert Marsh, Marina Talamonti, Marshall S. Baker, Mitchell C. Posner, Kevin K. Roggin, Jeffrey B. Matthews, Daniel V.T. Catenacci, Mark Kozloff, Blasé N. Polite, (unknown), Chi Wang, Hedy L. Kindler	26
15	Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer 2016 ·Clinical Cancer Research ·Giuseppe Toffoli, Manish Sharma, Elena Marangon, Bianca Posocco, Elizabeth Gray, Quan Mai, Angela Buonadonna, Blasé N. Polite, Gianmaria Miolo, (unknown), Federico Innocenti	31
16	Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide 2015 ·Clinical Cancer Research ·Peter H. O’Donnell, (unknown), Theodore Karrison, Linda Janisch, (unknown), Pamela Jo Harris, Blasé N. Polite, Ezra E.W. Cohen, Gini F. Fleming, Mark J. Ratain, Michael L. Maitland	4
17	Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies 2014 ·Clinical Cancer Research ·Ravi Salgia, Premal H. Patel, John Bothos, Wei Yu, Steve Eppler, Priti S. Hegde, Shuang Bai, Surinder Kaur, Ihsan Nijem, Daniel V.T. Catenacci, Amy Peterson, Mark J. Ratain, Blasé N. Polite, Janice M. Mehnert, Rebecca A. Moss	56
18	Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma 2012 ·Clinical Cancer Research ·Richard S. Finn, Yoon‐Koo Kang, Mary F. Mulcahy, Blasé N. Polite, Ho Yeong Lim, Ian Walters, Christine Baudelet, (unknown), Joong‐Won Park	158
19	Interventions to Improve Care Related to Colorectal Cancer Among Racial and Ethnic Minorities: A Systematic Review 2012 ·Journal of General Internal Medicine ·Keith Naylor, James E. Ward, Blasé N. Polite	124
20	Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution 2011 ·Clinical Cancer Research ·Brooke E. Sylvester, Dezheng Huo, Andrey Khramtsov, Jing Zhang, Rana V. Smalling, Sope Olugbile, Blasé N. Polite, Olufunmilayo I. Olopade	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact